Endocrine Abstracts

Bempedoic acid, an innovative medication targeting cholesterol synthesis through ATP citrate lyase inhibition, gained FDA and EMA approval in February 2020 for familial hypercholesterolemia and cardiovascular disease. UK NICE TA694, on April 28, 2021, extended its recommendation to include Bempedoic acid with ezetimibe for primary hypercholesterolaemia and mixed dyslipidaemia in adults, alongside dietary measures. This retrospective clinical audit assessed Bempedoic acid’...

Introduction: Cushing’s syndrome is rare disease with annual incidence 2/ million. It carries a high mortality rate if untreated. ACTH independent Cushing’s with Adrenal adenoma is responsible for 10% of cases. This is a case of a young gentleman with back pain, vertebral fracture, in presence of left adrenal incidentaloma, normal MRI pituitary, and hormonal profile indicative of possible non-detectable central pituitary lesion, diagnosis of likely adrenal Cushing&#1...